Quarter Financials

Karyopharm Therapeutics Inc. (KPTI)

$4.4

-0.21 (-4.56%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3
Net Income -49-4139-52-54-57-43-53
Dividend Paid --------
Retained Earnings -1,269-1,220--1,217-1,166-1,112-1,070-1,026

PPE Schedule

Year 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3
Capital Expenditure -0-0-----0-
Net PPE 9921010111212

Intangible and Goodwill Schedule

Year 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3
New Purchases -42-27-26-9-10--36-63
Intangible and Goodwill --------